Renpho

Longevity Card launches £415k crowdfunding campaign

Latest articles

The Sheekey Science Show: NAD+ rejuvenation strategies

NAD+ metabolism in aging & three strategies to rejuvenate. Welcome to The Sheekey Science Show! Longevity.Technology is delighted to partner with YouTube sensation Eleanor Sheekey (interviewed...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

BioAge kicks off Phase 2 longevity clinical trial

Company reveals primary indicator for BGE-117 clinical trial is unexplained anaemia of aging. Hot on the heels of its monster $90 million Series C funding...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Apollo Neuro

Editor's picks

The Sheekey Science Show: NAD+ rejuvenation strategies

NAD+ metabolism in aging & three strategies to rejuvenate. Welcome to The Sheekey Science Show! Longevity.Technology is delighted to partner with YouTube sensation Eleanor Sheekey (interviewed...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...
Renpho

Longevity focused FinTech launches equity crowdfunding campaign on Seedrs with 60% of target already reached.

UK-based FinTech company Longevity Card has today launched a crowdfunding campaign on equity crowdfunding platform, Seedrs. Longevity Card is bringing new financial products to market, specifically designed for customers aiming to live long, healthy lives, and who want to remain high functioning and financially stable throughout.

Initially targeting a goal of raising £415,000, offering investors a convertible round, the company’s campaign is already more than 60% funded.

Longevity.Technology: Having already raised well over half of its initial target, we expect that Longevity Card will smash through their fundraising goal with ease. Stay tuned for an exclusive interview with Sergey Balasanyan, the company’s CEO and co-founder in the coming days.

Initially founded with financial backing from Deep Knowledge Ventures, Longevity Card’s target audience is people who strive to live longer, healthier lives, and incentivises them with rewards for leading a healthier lifestyle. In a statement, Balasanyan said that the decision to crowdfund was driven by a vision to build a strong community around the campaign.

“We wanted to open up investment opportunities to our community first, so they would have priority access to invest along with VC funds that directly approach us, giving everyone a fair and equal chance to become a part of the Longevity Card journey.”

Longevity Card will use the funds raised by the crowdfunding campaign to expand its team, increase its user base and market its solution to health and financial wellbeing-focused audiences.

In addition to providing digital multi-currency current accounts and a debit Mastercard, Longevity Card offers its customers discounts on a variety of health, fitness, wellness, life and health insurance products and services. These are offered via the company’s portfolio of partners, which currently consists of more than 60 companies, including Transferwise, Babylon Health, F45, Headspace, Urban, FiiT and others.

 


 

“Health is the new wealth”

 


 

The company’s first Mastercard debit cards are now live and its mobile app is due for public launch in the first quarter of 2021.

“Health is the new wealth,” said Balasanyan. “It is quite clear that this global crisis will have long-lasting effects. People and financial institutions now have a newfound understanding of their priorities, and the concept of health and longevity will receive greater ­attention and will be rightly considered as a ­tangible and precious asset of equal standing to financial health. By combining these two components, Longevity Card allows our customers to take care of their health and their wealth, at the same time, in one app.”

The neobank also aims to motivate its customers to lead healthier lifestyles via its mobile app’s mHealth integration. This AI-powered feature tracks users’ fitness activity via wearables and rewards them with additional “Longevity Points” which can be converted into exclusive offers from its partner marketplace, as well as cashback options. Longevity Points can also be earned by regularly using the current accounts for payments, cash withdrawals, international transfers, currency exchange and so on.

Looking ahead, Longevity Card aims to obtain its own banking licence and become a fully authorised financial institution in order to provide customers with additional financial products such as loans and deposits.

Comment on this article

Danny Sullivan
Contributing Editor Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
Renpho

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...

It’s time to sit up and take notice of mitochondria

CohBar CEO on the development of a “true portfolio” of mitochondria based therapeutics. US biotech company CohBar is developing mitochondria-based therapeutics for the treatment of...
Apollo Neuro

Related articles

Leading NAD+ company ChromaDex announces $25m raise

LA-based company ChromaDex announces that it has entered into a securities purchase agreement for the sale of $25m of its common stock in a...

Andreessen Horowitz leads $7m seed funding: Bold

Digital health and wellness company bags $7 million in seed funding led by Andreessen Horowitz. Bold focuses on disease prevention and healthy aging. Using personalised and...

Charles River to acquire Cognate BioServices for $875m

Charles River Laboratories signs $875 million cash deal to acquire cell and gene manufacturer Cognate BioServices. Charles River has announced plans to acquire Cognate BioServices,...

$1.1B biotech SPAC good news for longevity

Bioengineered human tissue company Humacyte nears biotech SPAC deal to go public. Humacyte, a transformative biotech platform company capable of manufacturing universally-implantable bioengineered human tissue...

The trillion dollar upside to longevity

New economic model estimates that targeting aging has larger economic gains than eradicating individual diseases: time for a policy pivot? Although life expectancy has increased...
TruNigen pf